DE69715910D1 - Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion - Google Patents

Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion

Info

Publication number
DE69715910D1
DE69715910D1 DE69715910T DE69715910T DE69715910D1 DE 69715910 D1 DE69715910 D1 DE 69715910D1 DE 69715910 T DE69715910 T DE 69715910T DE 69715910 T DE69715910 T DE 69715910T DE 69715910 D1 DE69715910 D1 DE 69715910D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
inhibiting
composition containing
containing peptides
receptor interaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69715910T
Other languages
English (en)
Other versions
DE69715910T2 (de
Inventor
Giorgio Fassina
Falco Sandro De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecnogen SpA
Original Assignee
Tecnogen SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen SpA filed Critical Tecnogen SpA
Publication of DE69715910D1 publication Critical patent/DE69715910D1/de
Application granted granted Critical
Publication of DE69715910T2 publication Critical patent/DE69715910T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69715910T 1996-12-16 1997-12-11 Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion Expired - Fee Related DE69715910T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002628A ITMI962628A1 (it) 1996-12-16 1996-12-16 Composizione farmaceutica
PCT/EP1997/007143 WO1998026794A1 (en) 1996-12-16 1997-12-11 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction

Publications (2)

Publication Number Publication Date
DE69715910D1 true DE69715910D1 (de) 2002-10-31
DE69715910T2 DE69715910T2 (de) 2003-05-22

Family

ID=11375401

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715910T Expired - Fee Related DE69715910T2 (de) 1996-12-16 1997-12-11 Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion

Country Status (13)

Country Link
US (1) US6426401B1 (de)
EP (1) EP0948345B1 (de)
JP (1) JP4071830B2 (de)
KR (1) KR100502074B1 (de)
CN (1) CN1216637C (de)
AT (1) ATE224724T1 (de)
AU (1) AU5858398A (de)
CA (1) CA2275213A1 (de)
DE (1) DE69715910T2 (de)
EA (1) EA001468B1 (de)
ES (1) ES2183237T3 (de)
IT (1) ITMI962628A1 (de)
WO (1) WO1998026794A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916904B2 (en) 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
EP1730170B1 (de) 2004-03-10 2020-02-19 Trinity Therapeutics, Inc. Verfahren zur inhibierung der immunkomplexbildung in einem probanden
ITMI20071119A1 (it) 2007-06-01 2008-12-02 Tecnogen Spa Nuovi ligandi sintetici per immunoglobuline e composizioni farmaceutiche che li comprendono
WO2010009380A2 (en) 2008-07-18 2010-01-21 Trinity Therapeutics, Inc. Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
AU2017277065A1 (en) 2016-06-06 2019-01-17 Medizinische Universität Wien Method for the detection of an IgM antibody specific for a flavivirus in a sample

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA846192B (en) * 1984-08-09 1986-03-26 Merck Patent Gmbh Immunotherapeutic polypeptide agents
EP0190127A1 (de) * 1984-08-10 1986-08-13 MERCK PATENT GmbH Immunotherapeutische polypeptidheilmittel
FR2655269B1 (fr) * 1989-12-01 1994-02-11 Curie Universite Pierre Marie Proteines empechant l'interaction entre un fragment fc d'une immunoglobuline et son recepteur et utilisation en therapeutique, notamment dans le traitement des affections liees aux virus hiv.
AU3002695A (en) * 1994-07-08 1996-02-09 King's College Ige antagonists
DK0752425T3 (da) * 1995-06-21 2000-04-10 Tecnogen Scpa Peptidligander for den konstante region på immunoglobuliner

Also Published As

Publication number Publication date
US6426401B1 (en) 2002-07-30
CN1240357A (zh) 2000-01-05
KR100502074B1 (ko) 2005-07-25
JP2001506994A (ja) 2001-05-29
CA2275213A1 (en) 1998-06-25
EA001468B1 (ru) 2001-04-23
DE69715910T2 (de) 2003-05-22
AU5858398A (en) 1998-07-15
EP0948345A1 (de) 1999-10-13
ATE224724T1 (de) 2002-10-15
ES2183237T3 (es) 2003-03-16
CN1216637C (zh) 2005-08-31
JP4071830B2 (ja) 2008-04-02
KR20000057634A (ko) 2000-09-25
EA199900551A1 (ru) 2000-02-28
WO1998026794A1 (en) 1998-06-25
EP0948345B1 (de) 2002-09-25
ITMI962628A0 (it) 1996-12-16
ITMI962628A1 (it) 1998-06-16

Similar Documents

Publication Publication Date Title
ES2107357A1 (es) Sales de peptidos con poliesteres carboxi-terminados.
EP1093372A4 (de) Aminosäureverbindungen, pharmazeutische zusammensetzungen damit und verfahren zur hemmung von a(b)-amyloid-peptid freisetzung und/oder deren synthese durch verwendung dieser verbindungen
HU9302762D0 (en) N-sulfonyl-2-oxoindole derivatives being effective on vasopressin and/or oxitocin receptors
ATE295346T1 (de) N-(aryl/heteroarylacetyl)aminosäureester, diese enthaltende pharmazeutische zusammensetzungen und methoden zur inhibierung der beta- amyloidfreisetzung und/oder deren synthese unter verwendung dieser verbindungen
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
CA2272990A1 (en) Heptapeptide oxytocin analogues
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
SI1078001T1 (sl) Il-6-antagonisticni peptidi
CS202568B2 (en) Process for preparing polypeptides
DE69715910D1 (de) Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion
EP0752425A3 (de) Peptidliganden für die konstante Region von Immunoglobulinen
DE69319733D1 (de) In der konformation beschränkte peptid analoge als wirkstoff gegen plättchenaggregation
EA199901012A1 (ru) Фармацевтические композиции на основе тизоксанида и нитазоксанида
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
NZ511618A (en) Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X
JPS57212148A (en) Aminoacyl derivative and opiate receptor antagonistic pharmaceutical composition containing same
KR970701732A (ko) 펩신 방출을 억제하기 위한 펩티드(Peptides Inhibiting the Release of Pepsin)
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
KR930017874A (ko) 포화 질소 헤테로사이클의 유도체
RU96118282A (ru) Пептиды для ингибирования высвобождения пепсина
ES2114220T3 (es) Peptido inhibidor de la fosfolipasa c.
KATZ et al. Synthesis, characterization and inhibitory activities of (4‐N3 [3, 5‐3H] Phe10) PKI (6–22) amide and its precursors: photoaffinity labeling peptides for the active site of cyclic AMP‐dependent protein kinase
Neustadt et al. A case study of combinatorial libraries: Endothelin receptor antagonist hexapeptides
ATE283276T1 (de) Deoxyhypusin reagenz und peptide
ZA934708B (en) Peptide compounds active in cell adhesion processes, a process for the preparation thereof, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee